Overview
Trophoblastic neoplasms encompass gestational trophoblastic tumors, including choriocarcinoma, placental site trophoblastic tumor, and hydatidiform mole, characterized by uncontrolled growth of trophoblastic cells following pregnancy 1.Diagnosis
Elevated serum β-hCG levels 1.
Histopathological examination of products of conception 1.
Imaging studies (ultrasound, MRI) to assess tumor extent 1.
Differential diagnosis from other pregnancy-related complications 1.Management
First-line chemotherapy: Single-agent or multi-agent regimens (e.g., EMA-CO: Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide, Vincristine) tailored to risk stratification 1.
Follow-up monitoring of β-hCG levels post-treatment to ensure normalization 1.
Surgical intervention (e.g., hysterectomy) considered in select cases or persistent disease 1.Special Populations
Pregnancy post-treatment: No increased risk of fetal wastage, congenital abnormalities, or complicated pregnancies observed in women previously treated with chemotherapy for trophoblastic neoplasms 1.Key Recommendations
Women treated with chemotherapy for trophoblastic neoplasms can safely conceive without increased risk of adverse pregnancy outcomes (Evidence: Moderate 1).
Post-treatment, closely monitor β-hCG levels to confirm remission (Evidence: Expert opinion).
Tailor chemotherapy regimens based on risk stratification, considering multi-agent protocols for higher-risk cases (Evidence: Moderate 1).References
1 Van Thiel DH, Ross GT, Lipsett MB. Pregnancies after chemotherapy of trophoblastic neoplasms. Science (New York, N.Y.) 1970. link